267 related articles for article (PubMed ID: 15915153)
21. Pharmacogenomics: questions and concerns.
Mahlknecht U; Voelter-Mahlknecht S
Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
[TBL] [Abstract][Full Text] [Related]
22. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
Leeder JS
Drug Discov Today; 2004 Jul; 9(13):567-73. PubMed ID: 15203092
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics in Europe: barriers and opportunities.
Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics: the promise of personalized medicine for CNS disorders.
de Leon J
Neuropsychopharmacology; 2009 Jan; 34(1):159-72. PubMed ID: 18800072
[TBL] [Abstract][Full Text] [Related]
25. Preparing for the revolution--pharmacogenomics and the clinical lab.
Mehr IJ
Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics: from bedside to clinical practice.
Marsh S; McLeod HL
Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
[TBL] [Abstract][Full Text] [Related]
27. The ethical implications of stratifying by race in pharmacogenomics.
Lee SS
Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
[TBL] [Abstract][Full Text] [Related]
28. Payer perspectives on pharmacogenomics testing and drug development.
Epstein RS; Frueh FW; Geren D; Hummer D; McKibbin S; O'Connor S; Randhawa G; Zelman B
Pharmacogenomics; 2009 Jan; 10(1):149-51. PubMed ID: 19102724
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics: historical perspective and current status.
Charlab R; Zhang L
Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
[TBL] [Abstract][Full Text] [Related]
30. FDA perspectives on pharmacogenetic testing.
Harper CC; Philip R; Robinowitz M; Gutman SI
Expert Rev Mol Diagn; 2005 Sep; 5(5):643-8. PubMed ID: 16149867
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
Issa AM
Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
[TBL] [Abstract][Full Text] [Related]
32. How molecular medicine transforms policy (and everything else).
Kean MA; Batchelder KF
J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
34. Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?
Johnson MR; Tan NC; Kwan P; Brodie MJ
Epilepsy Behav; 2011 Sep; 22(1):3-8. PubMed ID: 21420909
[TBL] [Abstract][Full Text] [Related]
35. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead.
Nebert DW; Vesell ES
Eur J Pharmacol; 2004 Oct; 500(1-3):267-80. PubMed ID: 15464039
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
37. Systems for the management of pharmacogenomic information.
Sturn A; Maurer M; Molidor R; Trajanoski Z
Methods Mol Biol; 2005; 311():193-208. PubMed ID: 16100409
[TBL] [Abstract][Full Text] [Related]
38. Relevance of pharmacogenomics for developing countries in Europe.
Mitropoulos K; Johnson L; Vozikis A; Patrinos GP
Drug Metabol Drug Interact; 2011; 26(4):143-6. PubMed ID: 22017487
[TBL] [Abstract][Full Text] [Related]
39. The value of routine pharmacogenomic screening-Are we there yet? A perspective on the costs and benefits of routine screening-shouldn't everyone have this done?
Veenstra DL
Clin Pharmacol Ther; 2016 Feb; 99(2):164-6. PubMed ID: 26565561
[TBL] [Abstract][Full Text] [Related]
40. Regulatory approval for new pharmacogenomic tests: a comparative overview.
Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D
Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
